Molecular Basis for Therapy of AIDS-Defining Cancers, 2010
Coordonnateurs : Dittmer Dirk P., Krown Susan E.
![Couverture de l’ouvrage Molecular Basis for Therapy of AIDS-Defining Cancers](https://images.lavoisier.fr/couvertures/1316706239.jpg)
Cancer incidences increase in people living with HIV/AIDS. Over 2 million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as well.
Recently, new rational targets for cancer therapy have emerged. But their application to the care of HIV+ patients is slow, because of concerns about the weakened immune status of the patients, because of possible drug interactions with HAART and because some of the AIDS defining cancer are rare.
Will provide an update of the latest treatments for AIDS defining cancers, a scientific rationale for established treatments and a review of novel molecularly-targeted treatment options, which have passed pre-clinical testing
Includes supplementary material: sn.pub/extras
Date de parution : 09-2014
Ouvrage de 256 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panierDate de parution : 06-2010
Ouvrage de 256 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panierThèmes de Molecular Basis for Therapy of AIDS-Defining Cancers :
Mots-clés :
AIDS; Epidemiology; HIV; HIV infection; HIV/AIDS; gene therapy; infection; infections; interferon; virus; infectious diseases